AI-generated summary
The authors built sorafenib-loaded mesoporous silica nanoparticles with a gold shell, aiming to combine chemotherapy with photothermal heating for liver cancer cells. In cell experiments, they report that under near infrared irradiation these particles produced a high cell inhibition rate and good compatibility, but the abstract describes only laboratory cell work.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract reports only cell-level experiments and does not state any animal or human testing.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.